Morinaga Confectionery Enters XPRIZE Healthspan: A Global Competition with $100 Million Prize for Human Rejuvenation
Morinaga Confectionery has announced its participation in XPRIZE Healthspan, a global competition offering $100 million in prizes aimed at reversing age-related declines. The company is conducting human trials focused on the functional ingredient 'piceatannol' to improve muscle, cognitive, and immune functions. Morinaga is collaborating with partners, including ASAGI Labs, to advance longevity research.
📋 Article Processing Timeline
- 📰 Published: March 28, 2026 at 00:23
- 🔍 Collected: March 28, 2026 at 21:59 (21h 36m after Published)
- 🤖 AI Analyzed: April 15, 2026 at 03:52 (413h 52m after Collected)
Morinaga Confectionery Co., Ltd. (Tokyo) is advancing research on the functional ingredient 'piceatannol' and has joined the XPRIZE Healthspan, a global competition with a $100 million prize pool. XPRIZE is a leading organization dedicated to solving humanity's most critical challenges through large-scale, open-innovation competitions. Morinaga aims to rejuvenate functions that decline with age, such as muscle strength, cognition, and immunity, through human trials centered on piceatannol. As part of its 2030 vision to transform into a 'Wellness Company,' Morinaga is leveraging piceatannol, which has been shown to increase the expression of sirtuin genes associated with longevity. The company is collaborating with ASAGI Labs and has received support for its longevity approach from KOSÉ Corporation, dotme Inc., and Nine Hours Inc., among others, to foster wider implementation.
FAQ
What competition is Morinaga Confectionery entering?
It is entering 'XPRIZE Healthspan,' a global competition with a $100 million prize pool aimed at rejuvenating age-related declines in muscle, cognitive, and immune functions.
What is the key ingredient in their research?
The research focuses on 'piceatannol,' a polyphenol component found in passion fruit seeds.